Last reviewed · How we verify
EU-approved Prolia — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
EU-approved Prolia (EU-approved Prolia) — Celltrion.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| EU-approved Prolia TARGET | EU-approved Prolia | Celltrion | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- EU-approved Prolia CI watch — RSS
- EU-approved Prolia CI watch — Atom
- EU-approved Prolia CI watch — JSON
- EU-approved Prolia alone — RSS
Cite this brief
Drug Landscape (2026). EU-approved Prolia — Competitive Intelligence Brief. https://druglandscape.com/ci/eu-approved-prolia. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab